ALKEM IN EQUITY
loading…—
Day range—
52-week range—
Market cap—
P/E · TTM—
As of—
| CUSTOMER | BASIS | EST ₹CR | RANGE | % REV | BUCKET | PERIOD | METHOD | CONF |
|---|---|---|---|---|---|---|---|---|
| United States | UNSTATED | — | — | — | SG&A | FY26 | EST | 75% |
| “Revenue from Operations: Country of Domicile - India 63,146.4 60,336.7 United States of America 16,715.4 13,803.4 Other Countries 8,272.6 5,498.4 Total 88,134.…” AR · +1 DOC | ||||||||
| BANKINDIABank of India | UNSTATED | — | — | — | — | FY26 | EST | 75% |
| “Notes: Enzene Biosciences Limited ('EBL') Term loan consist of C800 Million loan sanctioned by Export-Import Bank of India (EXIM bank) under Exim bank's Ubhart…” AR · +1 DOC | ||||||||
| United States | UNSTATED | — | — | — | — | FY26 | EST | 75% |
| “These exports span more than 200 countries and territories, including stringent regulatory markets such as the United States, the United Kingdom, the European …” AR · +1 DOC | ||||||||
| Australia | UNSTATED | — | — | — | — | FY25 | EST | 75% |
| “Today, we serve nearly 40 international markets beyond the US, ranging from Latin America and Europe to Southeast Asia, Africa, Australia and other emarging ma…” AR DOC | ||||||||
| CRISILCRISIL Ltd. | UNSTATED | — | — | — | — | FY25 | EST | 75% |
| “He is also serving as an Independent Director on the Boards of CRISIL Ratings Ltd, CRISIL ESG Ratings & Analytics Ltd., Mahindra Holidays & Resorts India Ltd. …” AR DOC | ||||||||
| Securities and Exchange Board of India | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “(f) The Securities and Exchange Board of India (Registrars to an Issue and Share Transfer Agents) Regulations, 1993 regarding the Companies Act and dealing wit…” AR · +1 DOC | ||||||||
| Authority. | UNSTATED | — | — | — | SG&A | FY26 | EST | 70% |
| “In order to educate the shareholders and with an intent to protect their rights, the Company sends regular notices to shareholders to claim their unclaimed div…” AR · +1 DOC | ||||||||
| Others | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “pdf 0 0 - 0 0 - Investors (other than shareholders) 0 0 - 0 0 - Shareholders 0 0 - 0 0 - Employees and workers 15 0 - 6 0 - Customers 116 0 - 116 0 - Value Cha…” AR DOC | ||||||||
| China. | UNSTATED | — | — | — | — | FY25 | EST | 70% |
| “it positions us closer to our key customers in the U.S. and allows us to tap into the “China+1” strategy, where biotech innovators are actively seeking alterna…” AR DOC | ||||||||
| United States | UNSTATED | — | — | — | R&D | FY26 | EST | 70% |
| “United States: The New Jersey facility, operated by Enzene Inc., expands the Company’s CDMO presence in North America: Clinical manufacturing began in March 20…” AR DOC | ||||||||
| CDSLCentral Depository Services (India) Ltd. | UNSTATED | — | — | — | — | FY26 | EST | 60% |
| “• Now Enter your User ID: a. For CDSL: 16 digits beneficiary ID b. For NSDL: 8 Character DP ID followed by 8 Digits Client ID, c. Shareholders holding shares i…” AR · +1 DOC | ||||||||
| SUPPLIER | BASIS | EST ₹CR | RANGE | % COST | BUCKET | PERIOD | METHOD | CONF |
|---|---|---|---|---|---|---|---|---|
| China. | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “Led by the China +1 strategy among large pharmaceutical markets, India is solidifying its position as a key global pharmaceutical supplier.” AR DOC | ||||||||
| United States | UNSTATED | — | — | — | — | FY25 | EST | 70% |
| “Regulatory Compliance and Global Standards Alkem’s manufacturing facilities comply with a broad spectrum of international Good Manufacturing Practices (GMP), i…” AR DOC | ||||||||
| Australia | UNSTATED | — | — | — | — | FY25 | EST | 70% |
| “Regulatory Compliance and Global Standards Alkem’s manufacturing facilities comply with a broad spectrum of international Good Manufacturing Practices (GMP), i…” AR DOC | ||||||||
| Office | UNSTATED | — | — | — | — | FY25 | EST | 70% |
| “Relationship with struck off companies: Name of Struck off company Nature of Transactions Transactions during the year 31 March, 2025 Balance o/s. at the end o…” AR DOC | ||||||||
| SOURCE | READ | % | LAST READ |
|---|---|---|---|
| ANNUAL | 2/2 | 100% | 15-OCT-26 |
| CONCALL | 4/4 | 100% | 15-OCT-26 |
| SCREENER | 1/1 | 100% | 08-NOV-26 |
| SIGNAL | VALUE | AS OF | INPUTS |
|---|---|---|---|
| CUST MOM 1M | +15.0% | 14-NOV-26 | from 15-OCT-26 · Bank of India +18.2% w 1 · Central Depository Services (India) Ltd. +11.9% w 1 |
| DISTRESS SCORE | 0.136 | 13-OCT-26 | roe 0.17 · operatingMargin 0.2 · debtToEquity 0.15 · interestCoverage 18.83 · assetTurnover 0.71 · leverage 1.51 |